최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.23 no.4, 2013년, pp.316 - 321
박진현 (영남대학교 약학대학) , 노금한 (영남대학교 약학대학) , 임미선 (영남대학교 약학대학) , 강원구 (영남대학교 약학대학)
Purpose: Atorvastatin, a HMG-CoA reductase inhibitor is widely prescribed in hyperlipidemic patients and telmisartan, an angiotensin receptor blocker is frequently used in the treatment of hypertension. Both drugs are substrates of organic anion transporting polypeptide (OATP) expressed in basolater...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
Telmisartan의 주요 배설경로는 무엇인가? | 1-4) 체내에 흡수된 telmisartan은 주로 간과 소장에서 1상 대사과정 없이 2상 대사만을 거치며3), 1-O-acylglucuronidation된 telmisartan이 주 대사체로 알려져 있다. 2) 주요 배설경로는 담즙과 대변이며(98%), 뇨를 통한 배설량은 전체 투여량의 1% 미만으로 보고되어 있다.4) | |
Telmisartan이란 무엇인가? | Telmisartan은 안지오텐신 II와 안지오텐신 II type 1 수용체의 결합을 경쟁적으로 저해하여 혈관수축작용을 억제하는 항고혈압 약물이다. Telmisartan은 다른 안지오텐신 II 수용체 차단제 계열의 약물에 비해 선택적인 작용과 반감기가 긴 장점으로 인해 고혈압 치료에 많이 사용되고 있다. | |
OATP란 무엇인가? | OATP (Organic Anion Transporting Polypeptide) 는 다양한 조직에서 기질 약물의 수송에 관여하며 기질 약물의 약동학에 중요한 역할을 한다고 알려진 막 수송 단백질이다. 특히, 간세포의 sinusoidal membrane에 주로 발현된 OATP1B1, 1B3와 2B1은 간세포 내로의 흡수에 관여한다. |
Stangier J, Su CA, Roth W. Pharmacokinetics of Orally and Intravenously Administered Telmisartan in Healthy Young and Elderly Volunteers and in Hypertensive Patients. J int Med Res 2000; 28: 149-67.
Wienen W, Entzeroth M, Van Meel JCA, et al. A Review on Telmisartan: A Novel, Long-Acting Angiotensin IIReceptor Antagonist. Cardiovasc Drug Rev 2000; 18: 127-54.
Ren S, Zeng J, Mei Y, et al. Discovery and Characterization of Novel, Potent, and Selective Cytochrome P450 2J2 Inhibitors. Drug Metab Dispos 2013; 41: 60-71.
Stangier J, Schmid J, Trck D, et al. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers. J Clin Pharmacol 2000; 40: 1312-22.
Lennerns H. Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet 2003; 42: 1141-60.
Kearney AS, Crawford LF, Mehta SC, et al. The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981. Pharm Res 1993; 10: 1461-5.
Grube M, Kck K, Oswald S, et al. Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clin Pharmacol Ther 2006; 80: 607-20.
Kalliokoski A. and Niemi M. REVIEW: Impact of OATP transporters on pharmacokinetics Br J Pharmacol 2009; 158: 693-705.
Ishiguro N, Maeda K, Kishimoto W, et al. Predominant contribution of OATP1b3 to the hepatic uptake of telmisartan, An angiotensin II receptor antagonist, in humans. Drug Metab Dispos 2006; 34: 1109-15.
Macwan JS, Ionita IA, Dostalek M, et al. Development and validation of a sensitive, simple, and rapid method for simultaneous quantitation of atorvastatin and its acid and lactone metabolites by liquid chromatography-tandem mass spectrometry(LC-MS/MS) Anal Bioanal Chem 2011; 400: 423-33.
Herv F, Urien S, Albengres E, et al. Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding. Clin Pharmacokinet 1944; 26: 44-58.
Vats R, Varanasi KV, Arla R, et al. Effect of multidose cilostazol on pharmacokinetic and lipid profile of atorvastatin in male Wistar rats. J Pharm Pharmacol 2012; 64: 1638-45.
Karlgren M, Vildhede A, Norinder U, et al. Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug-Drug Interactions. J Med Chem 2012; 55: 4740-63.
Lins RL, Matthys KE, Verpooten GA, et al. Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 967-76.
Lau YY, Okochi H, Huang Y, et al. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Drug Metab Dispos 2006; 34: 1175-81.
DeGorter MK, Ho RH, Leake BF, et al. Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity. Mol Pharm 2012; 9: 986-95.
Kalliokoski A, Backman JT, Kurkinen KJ, et al. Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism. Clin Pharmacol Ther 2008; 84: 488-96.
Hermann M, Asberg A, Christensen H, et al. Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients. Clin Pharmacol Ther 2004; 76: 388-91.
Lemahieu WP, Hermann M, Asberg A, et al. Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. Am J Transplant 2005; 5: 2236-43.
Backman JT, Luurila H, Neuvonen M, et al. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites. Clin Pharmacol Ther 2005; 78: 154-67.
Lau YY, Huang Y, Frassetto L, et al. effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clin Pharmacol Ther 2007; 81: 194-204.
Yoon H, Osun B. Drug interaction of warfarin with simvastatin/gemfibrozil: high levels of ALT/AST, rhabdomyolysis and acute renal failure. Kor J Clin Pharm 2011; 21: 270-5.
Choi MK, Bang JS, Lee YJ. Patterns of over-the-counter drug use and interactions between over-the counter drugs and prescription drugs in adults visiting a community pharmacy. Kor J Clin Pharm 2013; 23: 49-56.
Miura M, Satoh S, Kagaya H, et al. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients. J Clin Pharm Ther 2009; 34: 683-92.
Kataoka M, Takashima T, Shingaki T, et al. Dynamic analysis of GI absorption and hepatic distribution processes of telmisartan in rats using positron emission tomography. Pharm Res 2012; 29: 2419-31.
Hao K, Chen YC, Cao YG, et al. Pharmacokineticpharmacodynamic modeling of telmisartan using an indirect response model in spontaneously hypertensive rats. Acta Pharmacol Sin 2007; 28: 738-48.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.